Damage to yeast cells ofCryptococcus neoformansby voriconazole and fluconazole: a culture and microscopic study
Open Access
- 1 January 1998
- journal article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 36 (4) , 227-233
- https://doi.org/10.1080/02681219880000341
Abstract
A systematic cultural, cytological and microscopic study of voriconazole (VCZ) and fluconazole (FCZ) damage to Cryptococcus neoformans over time was made. When haemocytometer counts were compared with colony-forming units(cfu) viability decreased with increased drug concentration and prolonged treatment time up to 48 h. Percentage viability by vitalstaining correlated with cfu. Concentrations of VCZ were foundto be 10-fold more potent than FCZ. At 72 h, percentage viability increased in cultures with lower drug concentrations, indicating outgrowth of surviving yeast cells. Drug treatment resulted in a cytological change in a large percentage of yeast cellscharacterized by a large central vacuole easily observed microscopically. Vital staining showed that there was no direct relationship between cytological changes and non-viability. These novelfindings add a new approach for studying the antifungal action of VCZ and FCZ against C. neoformans and provide a new perspective on their antifungal action.Keywords
This publication has 15 references indexed in Scilit:
- In vitro evaluation of voriconazole against some clinically important fungiAntimicrobial Agents and Chemotherapy, 1997
- Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida speciesAntimicrobial Agents and Chemotherapy, 1997
- Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemiaBritish Journal of Haematology, 1997
- Study of the role of iron in the anticryptococcal activity of human serum and fluconazoleMycopathologia, 1996
- Different components in human serum inhibit multiplication of Cryptococcus neoformans and enhance fluconazole activityAntimicrobial Agents and Chemotherapy, 1995
- Macrophage Colony-Stimulating Factor (M-CSF) Induction of Enhanced Anticryptococcal Activity in Human Monocyte-Derived Macrophages: Synergy with Fluconazole for KillingCellular Immunology, 1995
- Effect of macrophage colony-stimulating factor on anticryptococcal activity of bronchoalveolar macrophages: synergy with fluconazole for killingAntimicrobial Agents and Chemotherapy, 1994
- Macrophage Colony-Stimulating Factor Induction of Enhanced Macrophage Anticryptococcal Activity: Synergy with Fluconazole for KillingThe Journal of Infectious Diseases, 1994
- Candidacidal activity of macrophages from three mouse strains as demonstrated by a new method: neutral red stainingMedical Mycology, 1987
- Comparative sensitivity of Histoplasma capsulatum conidiospores and blastospores to oxidative antifungal systemsInfection and Immunity, 1981